These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23828022)

  • 1. Temocillin disc diffusion susceptibility testing by EUCAST methodology.
    Vanstone GL; Dilley R; Schwenk S; Williams A; Balakrishnan I
    J Antimicrob Chemother; 2013 Nov; 68(11):2688-9. PubMed ID: 23828022
    [No Abstract]   [Full Text] [Related]  

  • 2. Temocillin susceptibility by BSAC methodology.
    Andrews JM; Jevons G; Walker R; Ashby J; Fraise AP
    J Antimicrob Chemother; 2007 Jul; 60(1):185-7. PubMed ID: 17550891
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the Phoenix automated system, the Etest method and broth microdilution in determining temocillin susceptibility of Enterobacteriaceae.
    Patel TA; Dilley R; Williams A; Vanstone GL; Balakrishnan I
    J Antimicrob Chemother; 2013 Jul; 68(7):1685-6. PubMed ID: 23416956
    [No Abstract]   [Full Text] [Related]  

  • 4. Consequences of revised CLSI and EUCAST guidelines for antibiotic susceptibility patterns of ESBL- and AmpC β-lactamase-producing clinical Enterobacteriaceae isolates.
    Hombach M; Mouttet B; Bloemberg GV
    J Antimicrob Chemother; 2013 Sep; 68(9):2092-8. PubMed ID: 23633681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates.
    Polsfuss S; Bloemberg GV; Giger J; Meyer V; Hombach M
    J Antimicrob Chemother; 2012 Jan; 67(1):159-66. PubMed ID: 21972269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temocillin and meropenem to discriminate resistance mechanisms leading to decreased carbapenem susceptibility with focus on OXA-48 in Enterobacteriaceae.
    Hartl R; Widhalm S; Kerschner H; Apfalter P
    Clin Microbiol Infect; 2013 May; 19(5):E230-2. PubMed ID: 23397897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EUCAST breakpoints can be used to interpret direct susceptibility testing of Enterobacteriaceae from urine samples.
    Sundqvist M; Olafsson J; Matuschek E
    APMIS; 2015 Feb; 123(2):152-5. PubMed ID: 25351570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of temocillin against prevalent ESBL- and AmpC-producing Enterobacteriaceae from south-east England.
    Livermore DM; Hope R; Fagan EJ; Warner M; Woodford N; Potz N
    J Antimicrob Chemother; 2006 May; 57(5):1012-4. PubMed ID: 16531428
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative in vitro activity of temocillin against clinical isolates of Enterobacteriaceae.
    Van Noyen R; Ursi JP; Rummens JL; Hubrechts JM; Drion S; Colaert J; Bellon A; Beert J
    Acta Clin Belg; 1988; 43(6):449-51. PubMed ID: 3239347
    [No Abstract]   [Full Text] [Related]  

  • 10. Temocillin susceptibility among Enterobacterales strains recovered from blood culture in France.
    Farfour E; Si Larbi AG; Cattoir V; Corvec S; Guillard T; Grillon A; Isnard C; Mérens A; Degand N; Billard-Pomares T; Fournier D; Bille E; Le Brun C; Plouzeau C; Flevin E; Yin N; Woerther PL; Lourtet J; Lesprit P; Le Monnier A;
    Diagn Microbiol Infect Dis; 2021 Jul; 100(3):115368. PubMed ID: 33813355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-gradient plate susceptibility testing of an Enterococcus and its L-form.
    Dietz CC; Metzger JB; Smith MA
    Am J Med Technol; 1973 Feb; 39(2):55-9. PubMed ID: 4701052
    [No Abstract]   [Full Text] [Related]  

  • 12. Consequences of switching from a fixed 2 : 1 ratio of amoxicillin/clavulanate (CLSI) to a fixed concentration of clavulanate (EUCAST) for susceptibility testing of Escherichia coli.
    Leverstein-van Hall MA; Waar K; Muilwijk J; Cohen Stuart J;
    J Antimicrob Chemother; 2013 Nov; 68(11):2636-40. PubMed ID: 23766488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefazolin and enterobacteriaceae: rationale for revised susceptibility testing breakpoints.
    Turnidge JD;
    Clin Infect Dis; 2011 Apr; 52(7):917-24. PubMed ID: 21427400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of four commercial methods for determining temocillin susceptibility of Escherichia coli.
    Rodriguez-Villalobos H; Cardentey-Reyes A; Thiroux C; Nonhoff C; Struelens MJ
    J Antimicrob Chemother; 2009 Apr; 63(4):832-4. PubMed ID: 19223303
    [No Abstract]   [Full Text] [Related]  

  • 15. Disagreements between disc diffusion, and MIC-based susceptibility categorizations of ertapenem versus ESBL producers.
    Samuel JR; Natarajan M; Rizkalla E; Livermore DM; Warner M; Jenkinson P
    J Antimicrob Chemother; 2005 Nov; 56(5):984-5. PubMed ID: 16188914
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of the Phoenix™ automated system and EUCAST breakpoints for antimicrobial susceptibility testing against isolates expressing clinically relevant resistance mechanisms.
    Giani T; Morosini MI; D'Andrea MM; García-Castillo M; Rossolini GM; Cantón R
    Clin Microbiol Infect; 2012 Nov; 18(11):E452-8. PubMed ID: 22909279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BSAC standardized disc susceptibility testing method (version 10).
    Andrews JM; Howe RA;
    J Antimicrob Chemother; 2011 Dec; 66(12):2726-57. PubMed ID: 21921076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Standardized disk tests for the determination of bacterial resistance ].
    von Graevenitz A; Heitz M; Lüthy R; Meyer J; Vischer W
    Schweiz Med Wochenschr; 1984 Aug; 114(31-32):1079-86. PubMed ID: 6436967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the EUCAST disc diffusion susceptibility testing method for Haemophilus influenzae based on the resistance mechanism to β-lactam antibiotics.
    García-Cobos S; Arroyo M; Pérez-Vázquez M; Aracil B; Oteo J; Campos J
    J Antimicrob Chemother; 2013 Jan; 68(1):159-63. PubMed ID: 23034712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breakpoints for intravenously used cephalosporins in Enterobacteriaceae--EUCAST and CLSI breakpoints.
    Kahlmeter G
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():169-74. PubMed ID: 18154542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.